Clinical Trial Update: Efficacy of Phentolamine in Prevention of Contrast-Associated Acute Kidney Injury After Complex PCI [Phase 2, Phase 3]

View source ↗

Summary

A phase 2/3 clinical trial update evaluating phentolamine for prevention of contrast-associated acute kidney injury after complex PCI.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Contrast-associated Acute Kidney Injury
• Coronary Artery Disease
• Coronary Syndrome

Drugs mentioned

• Phentolamine (phentolamine)

Snippet

Sponsor: Helwan University | Conditions: CA-AKI - Contrast-Associated Acute Kidney Injury, Coronary Artery Disease | Phase 2, Phase 3 | Status: UNKNOWN